Holen Sie sich die Stockscreener-App
6.1463
0.74%
0.0463
Schlusskurs vom Vortag:
$6.10
Offen:
$6.1
24-Stunden-Volumen:
332.67K
Relative Volume:
0.58
Marktkapitalisierung:
$471.20M
Einnahmen:
$1,000.00K
Nettoeinkommen (Verlust:
$-48.81M
KGV:
-7.944
EPS:
-0.7737
Netto-Cashflow:
$-39.95M
1W Leistung:
+6.13%
1M Leistung:
-20.61%
6M Leistung:
+188.50%
1J Leistung:
+468.98%
1-Tages-Spanne:
$5.94
$6.155
1-Wochen-Bereich:
$5.86
$6.39
52-Wochen-Spanne:
$0.712
$8.33
Shattuck Labs Inc Stock (STTK) Company Profile
Firmenname
Shattuck Labs Inc
Sektor
Branche
Telefon
512-900-4690
Adresse
500 W. 5TH STREET, AUSTIN
Compare STTK vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
6.145 | 467.75M | 1,000.00K | -48.81M | -39.95M | -0.7737 |
VRTX
Vertex Pharmaceuticals Inc
|
436.73 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.57 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
805.44 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
294.70 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.28 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2026-03-06 | Fortgesetzt | Needham | Buy |
| 2026-01-28 | Eingeleitet | Piper Sandler | Overweight |
| 2025-12-01 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-09-08 | Eingeleitet | Wedbush | Outperform |
| 2025-03-17 | Eingeleitet | Leerink Partners | Outperform |
| 2024-10-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-10-02 | Herabstufung | Needham | Buy → Hold |
| 2024-10-01 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-08-31 | Eingeleitet | BTIG Research | Buy |
| 2022-06-01 | Eingeleitet | Citigroup | Buy |
| 2022-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-14 | Eingeleitet | Berenberg | Buy |
| 2021-01-11 | Eingeleitet | Evercore ISI | Outperform |
| 2020-11-03 | Eingeleitet | Citigroup | Buy |
| 2020-11-03 | Eingeleitet | Cowen | Outperform |
| 2020-11-03 | Eingeleitet | Needham | Buy |
Alle ansehen
Shattuck Labs Inc Aktie (STTK) Neueste Nachrichten
Shattuck Labs (STTK) Holds Steady at $6.1, Testing Familiar Support LevelsOBV Breakout - Newser
STTK Q1 2026 Earnings: Narrower-than-expected loss highlights cost discipline amid pre-revenue stageAnnual Report - Newser
Number of shareholders of Shattuck Labs, Inc. – NASDAQ:STTK - TradingView
STTK Insider Buying: CTO Shukla Acquires 5,122 Shares on May 22, 2026 - Meyka
Shattuck Labs (NASDAQ: STTK) CTO exercises 5,122 warrants and increases share holdings - Stock Titan
Shattuck Labs: Priced As If Risk Was Not A Part Of The Equation (NASDAQ:STTK) - Seeking Alpha
Here's Why We're Not Too Worried About Shattuck Labs' (NASDAQ:STTK) Cash Burn Situation - Sahm
Officer at Shattuck Labs (NASDAQ: STTK) exercises warrants for 12,805 shares - Stock Titan
Shattuck Labs (STTK) Stock Analysis: -6.15% Loss — Key Levels 2026-05-15Social Trading Insights - newser.com
Shattuck Labs (STTK) Declines -6.15% Amid Market Weakness 2026-05-15Trading Community - newser.com
Shattuck Labs (STTK) Delivers Q1 2026 Beat — EPS $-0.13 vs $-0.14 ExpectedSpecial Dividend - newser.com
T. Rowe Price holds 9.87M shares of Shattuck Labs (NASDAQ: STTK) amendment - Stock Titan
Insider Sell: Arundathy Pandite Sells 30,000 Shares of Shattuck Labs Inc (STTK) - GuruFocus
Shattuck Labs CMO Pandite sells $198,300 in stock By Investing.com - Investing.com Australia
Shattuck Labs CTO Abhinav Shukla sells $14,244 in shares - Investing.com UK
Shattuck Labs CMO Pandite sells $198,300 in stock - Investing.com
Shattuck Labs CTO Abhinav Shukla sells $14,244 in shares By Investing.com - Investing.com Australia
[Form 4] Shattuck Labs, Inc. Insider Trading Activity - Stock Titan
Shattuck Labs (STTK) CMO sells 30K shares under 10b5-1 plan - Stock Titan
Shattuck Labs stock (US8124231002): Down 5.29% in May 2026 amid biotech volatility - AD HOC NEWS
Shattuck Labs (STTK) CEO exercises warrants to acquire 25,610 common shares - Stock Titan
Shattuck Labs (NASDAQ: STTK) executive reports 968-share tax withholding - Stock Titan
[144] Shattuck Labs, Inc. SEC Filing - Stock Titan
We're Not Very Worried About Shattuck Labs' (NASDAQ:STTK) Cash Burn Rate - Yahoo Finance
STTK Maintained by Wedbush -- Price Target Raised to $11.00 - GuruFocus
Shattuck Labs Price Target Raised to $11.00/Share From $8.00 by Wedbush - Moomoo
Wedbush Raises Price Target on Shattuck Labs to $11 From $8, Keeps Outperform Rating - Moomoo
SL-325 Data Catalysts and Phase 2 Launch Plans Underpin Buy Rating on Shattuck Labs - TipRanks
Shattuck Labs | 8-K: Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights - Moomoo
Shattuck Labs Releases Q1 2026 Financial Results - AlphaStreet
Shattuck Labs (NASDAQ: STTK) posts higher Q1 2026 loss but strengthens cash - Stock Titan
Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights - Investing News Network
Shattuck Labs (NASDAQ: STTK) posts Q1 2026 loss as DR3 program advances - Stock Titan
Shattuck Labs 1Q Rev $0.00 >STTK - Moomoo
Shattuck Labs, Inc. Completes Enrollment in Phase 1 Clinical Trial of SL-325, with Phase 2 Trial Planned for 2026 - Quiver Quantitative
Shattuck’s Crohn’s drug candidate clears enrollment, with Q2 data due - Stock Titan
BRIEF-Shattuck Labs Q1 Net Income USD -14.767 Million - TradingView
Press Release: Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights - Moomoo
Shattuck Labs 1Q Loss/Shr 13c >STTK - Moomoo
Shattuck Labs Stock Surges Following Positive Analyst Coverage - HarianBasis.co
Cantor Fitzgerald Initiates Coverage of Shattuck Labs (STTK) - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL) and Shattuck Labs (STTK) - The Globe and Mail
Shattuck Labs (STTK) to Release Earnings on Thursday - MarketBeat
5 Best Performing Small Cap Stocks So Far in 2026 - Insider Monkey
Cantor Fitzgerald initiates coverage of Shattuck Labs (STTK) with overweight recommendation - MSN
Shattuck Labs (STTK) price target increased by 24.00% to 12.65 - MSN
Finanzdaten der Shattuck Labs Inc-Aktie (STTK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Shattuck Labs Inc-Aktie (STTK) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Shukla Abhinav A. | Chief Technical Officer |
May 12 '26 |
Sale |
7.01 |
2,032 |
14,244 |
81,258 |
| Pandite Arundathy N. | Chief Medical Officer |
May 12 '26 |
Sale |
6.61 |
30,000 |
198,300 |
166,219 |
2.25%
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):